Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2023-07-12 00:00:00 ET · period of report 2023-07-10 · accession 0001209191-23-042114 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-07-12 | 2023-07-10+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +1,903 | 528.5K | +0.4% | +$1,161 |
| DM | 2023-07-12 | 2023-07-10+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.04 | -1,903 | 528.0K | -0.4% | -$30.5K |
| DM | 2023-07-12 | 2023-07-10+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.00 | -1,903 | 140.0K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-12 | M | A | 201 | $0.61 | 528,182 | D | — | — | |
| 2 | Common | Common Stock | 2023-07-10 | S | D | 1,202 | $16.01 | 527,981 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.12. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 3 | Common | Common Stock | 2023-07-10 | M | A | 1,202 | $0.61 | 529,183 | D | — | — | |
| 4 | Common | Common Stock | 2023-07-12 | S | D | 201 | $16.23 | 527,981 | D | — | — | (F4) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.07 to $16.39. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 5 | Common | Common Stock | 2023-07-11 | M | A | 500 | $0.61 | 528,481 | D | — | — | |
| 6 | Common | Common Stock | 2023-07-11 | S | D | 500 | $16.02 | 527,981 | D | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.06. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-07-11 | M | D | 500 | $0.00 | 140,211 | D | $0.61 · — to 2030-01-26 | 500 Common Stock | (F5) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-07-10 | M | D | 1,202 | $0.00 | 140,711 | D | $0.61 · — to 2030-01-26 | 1,202 Common Stock | (F5) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-07-11 | M | D | 201 | $0.00 | 140,010 | D | $0.61 · — to 2030-01-26 | 201 Common Stock | (F5) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |